-
-
-
-
-
-
-
Barclays Starts Bristol-Myers Squibb Co. (BMY) at Overweight
-
-
-
-
-
-
-
Bristol-Myers Squibb (BMY) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY26 Guidance
-
-
-
-
-
-
-
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
-
-
-
-
-
-
-
Bristol Myers Squibb strikes deal with US government on drug pricing
-
-
-
-
-
-
-
FDA approves Bristol Myers Squibb Breyanzi for marginal zone lymphoma
-
-
-
-
-
-
-
Bristol Myers Squibb gains European approval for Breyanzi in mantle cell lymphoma
-
-
-
-
-
-
-
Bernstein on Bristol-Myers Squibb Co. (BMY): 'Key Catalysts Carrying More Risk Than Ever'
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

